Sale!

Maternal Serum Screen 4 Quadruple Test Cost

Original price was: 860 د.إ.Current price is: 770 د.إ.

-10%

The Maternal Serum Screen 4 Quadruple Test, commonly referred to as the Quad Screen, is a prenatal test offered at DNA Labs UAE, designed to evaluate the likelihood of certain genetic conditions in a developing fetus. Priced at 770 AED, this non-invasive blood test is conducted during the second trimester of pregnancy, typically between the 15th and 20th weeks. It measures four specific substances in the mother’s blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), estriol, and inhibin A.

The Quad Screen is primarily used to assess the risk of the fetus having Down syndrome (trisomy 21), trisomy 18 (Edwards syndrome), and neural tube defects such as spina bifida. It is important to note that this test does not diagnose these conditions but rather indicates a higher or lower risk, potentially leading to further diagnostic testing. DNA Labs UAE provides this service with professionalism and care, ensuring expectant mothers receive comprehensive support and information regarding their pregnancy health.

Description

MATERNAL SERUM SCREEN 4 QUADRUPLE Test

Test Name: MATERNAL SERUM SCREEN 4 QUADRUPLE Test

Test Components: AFP, Beta HCG, Free Estriol, Inhibin A, Risk Evaluation

Test Cost: AED 770.0

Sample Condition: 3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisition form (Form 11) is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks).

Report Delivery: Sample Mon through Sat by 9 am; Report Same day

Method: Chemiluminescent Immunoassay

Test Type: Prenatal Diagnosis

Doctor: Gynecologist

Test Department: Pre Test Information

Pre Test Information: Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisition form (Form 11) is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks).

Test Details: The Maternal Serum Screen 4 Quadruple Test is a prenatal screening test that measures the levels of four substances in the mother’s blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A. These substances can provide information about the risk of certain birth defects and genetic disorders in the fetus. The test is typically done between 15 and 20 weeks of pregnancy.

Test Name	MATERNAL SERUM SCREEN 4 QUADRUPLE Test Test
Components	AFPBeta HCGFree EstriolInhibin A *Risk Evaluation.
Price	770.0 AED
Sample Condition	3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Provide maternal Date of birth (dd\/mm\/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single\/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisitionform (Form 11) is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks).
Report Delivery	Sample Mon through Sat by 9 am; Report Same day
Method	Chemiluminescent Immunoassay
Test type	Prenatal Diagnosis
Doctor	Gynecologist
Test Department:
Pre Test Information	Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisitionform (Form 11) is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks).
Test Details	The Maternal Serum Screen 4 Quadruple Test is a prenatal screening test that measures the levels of four substances in the mother’s blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A. These substances can provide information about the risk of certain birth defects and genetic disorders in the fetus. The test is typically done between 15 and 20 weeks of pregnancy.